Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alzheimer's disease
Pharma
Eisai execs flag Leqembi 'expansion phase' on the horizon
Some two years into Leqembi’s launch, Eisai believes its Alzheimer's-fighting antibody could be finally nearing a “growth expansion phase."
Fraiser Kansteiner
Feb 11, 2025 12:06pm
Weight loss drugs from Lilly, Novo may cut risk of Alzheimer's
Jan 21, 2025 2:45pm
Analysts tip Lilly to drive eightfold Alzheimer's market boom
Jan 17, 2025 9:00am
EMA changes tune, endorses Leqembi with restriction
Nov 14, 2024 12:10pm
Biogen raises profit guidance as Leqembi's launch trudges on
Oct 30, 2024 12:30pm
Lilly's adjusted Kisunla regimen reduces brain swelling in trial
Oct 29, 2024 3:38pm